Vimarsana
Biggest News Aggregation in the World

Ava Amini News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ava Amini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ava Amini Today - Breaking & Trending Today

Three Companies Rocking AI In Medicine - Vimarsana News

Three Companies Rocking AI In Medicine

AI is having amazing effects on the world of medicine.

Source: forbes.com
Microsoft open sources EvoDiff, a novel protein-generating AI - Vimarsana News

Microsoft open sources EvoDiff, a novel protein-generating AI

It entails coming up with a protein structure that could plausibly perform a specific task inside the body, then finding a protein sequence -- the sequence of amino acids that make up a protein -- likely to "fold" into that structure. This week, Microsoft introduced a general-purpose framework, EvoDiff, that the company claims can generate "high-fidelity," "diverse" proteins given a protein sequence. Available in open source, EvoDiff could be used to create enzymes for new therapeutics and drug delivery methods as well as new enzymes for industrial chemical...

Source: yahoo.com
Related Topics:
Ava AminiSarah Alamdari
Microsoft open sources EvoDiff, a novel protein-generating AI - Vimarsana News

Microsoft open sources EvoDiff, a novel protein-generating AI

Microsoft has open sourced EvoDiff, an AI system and framework that can generate proteins without needing a protein sequence.

Biotech labs are using AI inspired by DALL-E to invent new drugs - Vimarsana News

Biotech labs are using AI inspired by DALL-E to invent new drugs

Two groups have announced powerful new generative models that can design new proteins on demand not seen in nature.

'Technological revolution': DALL-E inspires biotech labs to invent new drugs - Vimarsana News

'Technological revolution': DALL-E inspires biotech labs to invent new drugs

Text-to-image AI model technology like OpenAI's DALL-E 2 has caused a stir in biotech labs.